Thomas E N Jonassen Selected Research

N- (3- (1- (2- nitrophenyl)- 1H- pyrrol- 2- yl)allylidenamino)guanidine

4/2015

Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas E N Jonassen Research Topics

Disease

4	Liver Cirrhosis (Hepatic Cirrhosis) 09/2006 - 03/2003
3	Inflammation (Inflammations) 03/2022 - 07/2011
3	Heart Failure 12/2013 - 02/2002
2	Obesity 03/2022 - 04/2015
2	Fibrosis (Cirrhosis) 03/2022 - 11/2005
2	Peritonitis 04/2015 - 07/2011
2	Hypertrophy 01/2004 - 03/2003
1	Multiple Sclerosis 03/2022
1	Autoimmune Diseases (Autoimmune Disease) 03/2022
1	Rheumatoid Arthritis 03/2022
1	Joint Diseases (Joint Disease) 04/2015
1	Arthritis (Polyarthritis) 04/2015
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2011
1	Ascites 11/2005
1	Tachycardia (Tachyarrhythmias) 10/2002
1	Acute Kidney Injury (Acute Renal Failure) 10/2002

Drug/Important Bio-Agent (IBA)

4	SodiumIBA 11/2005 - 02/2002
3	MelanocortinsIBA 03/2022 - 07/2011
3	Vasopressins (Vasopressin)IBA 12/2013 - 07/2004
2	Aquaporin 2IBA 12/2013 - 07/2004
2	Proteins (Proteins, Gene)FDA Link 12/2013 - 10/2004
2	LipopolysaccharidesIBA 01/2011 - 10/2002
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2022
1	setmelanotideIBA 03/2022
1	Pharmaceutical PreparationsIBA 03/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2015
1	N- (3- (1- (2- nitrophenyl)- 1H- pyrrol- 2- yl)allylidenamino)guanidineIBA 04/2015
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 12/2013
1	Aquaporins (Water Channels)IBA 12/2013
1	ZymosanIBA 07/2011
1	Peptides (Polypeptides)IBA 07/2011
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2011
1	EndotoxinsIBA 01/2011
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2006
1	Octreotide (Sandostatin)FDA LinkGeneric 09/2006
1	11-beta-Hydroxysteroid Dehydrogenases (11beta Hydroxysteroid Dehydrogenase)IBA 11/2005
1	Epithelial Sodium ChannelsIBA 11/2005
1	Opioid Receptors (Opioid Receptor)IBA 07/2004
1	RNA (Ribonucleic Acid)IBA 01/2004
1	Furosemide (Lasix)FDA LinkGeneric 03/2003
1	Natriuretic AgentsIBA 03/2003
1	Milrinone (Primacor)FDA LinkGeneric 10/2002
1	4- (3- Butoxy- 4- methoxybenzyl)- 2- imidazolidinoneIBA 10/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2002
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 10/2002
1	Phosphodiesterase 4 InhibitorsIBA 10/2002
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2002
1	Phosphodiesterase 3 InhibitorsIBA 10/2002
1	Losartan (Cozaar)FDA LinkGeneric 02/2002

Therapy/Procedure

4	Ligation 09/2006 - 02/2002
1	Therapeutics 04/2015
1	Denervation 03/2003